Clinical Trial Update: A Performance Evaluation of the Enlite 3 Sensor [NA]

View source ↗

Summary

An evaluation trial for the Enlite 3 continuous glucose monitoring sensor in Type 1 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Enlite 3 Sensor

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes | NA | Status: WITHDRAWN